Matches in Wikidata for { <http://www.wikidata.org/entity/Q94067958> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q94067958 description "article scientifique publié en 2018" @default.
- Q94067958 description "wetenschappelijk artikel" @default.
- Q94067958 description "наукова стаття" @default.
- Q94067958 name "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 name "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 type Item @default.
- Q94067958 label "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 label "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 prefLabel "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 prefLabel "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 P1433 Q94067958-87F78262-3FBF-49A0-9EFD-5E317308D5F5 @default.
- Q94067958 P1476 Q94067958-DDB322A2-24F0-4FFB-A092-861CB0B0F39F @default.
- Q94067958 P2093 Q94067958-0211334F-1605-4E65-8C0C-5488994C26AD @default.
- Q94067958 P2093 Q94067958-10D122DF-9860-4279-825C-E6DFC95850D9 @default.
- Q94067958 P2093 Q94067958-342CD389-5754-4E0F-A50B-CCF2B15D9942 @default.
- Q94067958 P2093 Q94067958-52425CA9-2135-4530-8681-E232FBD785B7 @default.
- Q94067958 P2093 Q94067958-55EA0807-3B6E-4071-BA0E-D93AF25192E4 @default.
- Q94067958 P2093 Q94067958-76A6D613-B9BA-4DE9-91AB-4B65665C511C @default.
- Q94067958 P2093 Q94067958-962FF07C-3E0A-4FB9-A78E-9A6D0611A9B3 @default.
- Q94067958 P2093 Q94067958-97245B4F-0879-44A6-80C7-8D45D3981297 @default.
- Q94067958 P2093 Q94067958-B5E02D21-39F8-4C18-99BD-AC6F237C4633 @default.
- Q94067958 P2093 Q94067958-B96ED8C8-C9B1-4310-8162-DAF42F0DB1AD @default.
- Q94067958 P2093 Q94067958-DCDD6013-3A84-4E23-8796-C2F3E57FB3AA @default.
- Q94067958 P2093 Q94067958-E0706459-85C5-4EC5-ADB6-DF4807FBA0E8 @default.
- Q94067958 P2093 Q94067958-ED6020A2-F388-4FB3-B285-20FBEF3BC633 @default.
- Q94067958 P304 Q94067958-52F94A15-7125-42D0-91F7-2CE578D5D9A0 @default.
- Q94067958 P31 Q94067958-79DA3720-4B9C-40AD-BC40-6BD0101B47D0 @default.
- Q94067958 P356 Q94067958-8F4F50C1-C650-45E3-9923-B670F80B0495 @default.
- Q94067958 P433 Q94067958-9E17C17E-51E1-4949-8D08-21A43BA9D2E1 @default.
- Q94067958 P478 Q94067958-B58C8F9A-493E-4C43-BCCC-F767B3B51382 @default.
- Q94067958 P50 Q94067958-76fc7952-427b-93cf-c363-19df2ca9db19 @default.
- Q94067958 P577 Q94067958-7DE482EC-A0BE-4AED-98DB-5489669BAAD6 @default.
- Q94067958 P921 Q94067958-1FAA6F53-352C-4867-B803-A5313766B87F @default.
- Q94067958 P921 Q94067958-5AD0AC31-4DDE-42D6-9F5E-064B1163622F @default.
- Q94067958 P921 Q94067958-9165C373-C388-49A6-A2EF-31A3FC206952 @default.
- Q94067958 P921 Q94067958-DDDC9FE3-45C8-485B-9E6A-2196AA174D92 @default.
- Q94067958 P932 Q94067958-01A974AF-3574-41A5-841F-8427B0507584 @default.
- Q94067958 P356 NOY059.517 @default.
- Q94067958 P1433 Q15724471 @default.
- Q94067958 P1476 "NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY" @default.
- Q94067958 P2093 "Bruce Korf" @default.
- Q94067958 P2093 "Coretta Thomas" @default.
- Q94067958 P2093 "D Wade Clapp" @default.
- Q94067958 P2093 "Jaishri Blakeley" @default.
- Q94067958 P2093 "James Tonsgard" @default.
- Q94067958 P2093 "Jeffrey Allen" @default.
- Q94067958 P2093 "Jian Campian" @default.
- Q94067958 P2093 "Matthias Karajannis" @default.
- Q94067958 P2093 "Michael Fisher" @default.
- Q94067958 P2093 "Nicole Ullrich" @default.
- Q94067958 P2093 "Roger Packer" @default.
- Q94067958 P2093 "Scott Plotkin" @default.
- Q94067958 P2093 "Tena Rosser" @default.
- Q94067958 P304 "i144-i144" @default.
- Q94067958 P31 Q13442814 @default.
- Q94067958 P356 "10.1093/NEUONC/NOY059.517" @default.
- Q94067958 P433 "Suppl 2" @default.
- Q94067958 P478 "20" @default.
- Q94067958 P50 Q89543066 @default.
- Q94067958 P577 "2018-06-22T00:00:00Z" @default.
- Q94067958 P921 Q1935832 @default.
- Q94067958 P921 Q413299 @default.
- Q94067958 P921 Q42824440 @default.
- Q94067958 P921 Q6934595 @default.
- Q94067958 P932 "6012828" @default.